The TGF‐β/TGF‐β‐RII signalling pathway has been show to comprise a tumour suppressor pathway (Hahm et al., 2002; Takeno et al., 2002) deregulated in gastric cancer (Li et al., 2015). This evidence concerns the gene TGFB1 and neoplasm.